<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Haruki H</dc:creator>
  <dc:creator>Hovius R</dc:creator>
  <dc:creator>Pedersen MG</dc:creator>
  <dc:creator>Johnsson K</dc:creator>
  <dc:date>2016</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Tryptophan metabolites in the kynurenine pathway are up-regulated by pro-inflammatory cytokines or glucocorticoids, and are linked to anti-inflammatory and immunosuppressive activities. In addition, they are up-regulated in pathologies such as cancer, autoimmune diseases, and psychiatric disorders. The molecular mechanisms of how kynurenine pathway metabolites cause these effects are incompletely understood. On the other hand, pro-inflammatory cytokines also up-regulate the amounts of tetrahydrobiopterin (BH4), an enzyme cofactor essential for the synthesis of several neurotransmitter and nitric oxide species. Here we show that xanthurenic acid is a potent inhibitor of sepiapterin reductase (SPR), the final enzyme in de novo BH4 synthesis. The crystal structure of xanthurenic acid bound to the active site of SPR reveals why among all kynurenine pathway metabolites xanthurenic acid is the most potent SPR inhibitor. Our findings suggest that increased xanthurenic acid levels resulting from up-regulation of the kynurenine pathway could attenuate BH4 biosynthesis and BH4-dependent enzymatic reactions, linking two major metabolic pathways known to be highly up-regulated in inflammation.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/96951</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1074/jbc.C115.680488</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/26565027</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>The Journal of biological chemistry. - 2016</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">chemical biology</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">crystal structure</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">inflammation</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">inhibition mechanism</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">kynurenine pathway</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">sepiapterin reductase</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">tetrahydrobiopterin (BH4)</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">xanthurenic acid</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Biopterin</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Calorimetry</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Crystallography, X-Ray</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Inhibitory Concentration 50</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Kynurenine</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Metabolic Networks and Pathways</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Mice</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Models, Molecular</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Rats</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Surface Plasmon Resonance</dc:subject>
  <dc:subject xmlns:ns21="xml" ns21:lang="en">Thermodynamics</dc:subject>
  <dc:subject xmlns:ns22="xml" ns22:lang="en">Xanthurenates</dc:subject>
  <dc:title xmlns:ns23="xml" ns23:lang="en">Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
